HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel M Murr Selected Research

protein kinase C zeta

5/2008Deletion of toll-like receptor-4 downregulates protein kinase C-zeta and attenuates liver injury in experimental pancreatitis.
12/2007Protein kinase C-zeta (PKC-zeta) regulates Kupffer cell apoptosis during experimental sepsis.
10/2007Protein kinase C-zeta is critical in pancreatitis-induced apoptosis of Kupffer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel M Murr Research Topics

Disease

13Obesity
01/2021 - 02/2003
11Pancreatitis
05/2008 - 05/2002
10Weight Loss (Weight Reduction)
01/2021 - 02/2003
5Anastomotic Leak
10/2007 - 02/2002
4Non-alcoholic Fatty Liver Disease
05/2020 - 11/2009
4Fatty Liver
03/2019 - 11/2009
4Morbid Obesity
11/2017 - 08/2005
3Inflammation (Inflammations)
01/2017 - 01/2006
3Obstructive Sleep Apnea
03/2007 - 02/2003
2Infections
01/2021 - 01/2006
2Wound Infection (Wound Infections)
01/2021 - 04/2006
2Liver Cirrhosis (Hepatic Cirrhosis)
03/2019 - 03/2015
2Constipation
12/2013 - 04/2006
2Neoplasms (Cancer)
09/2009 - 10/2004
1Vomiting
04/2021
1Food Intolerance
04/2021
1Deglutition Disorders (Dysphagia)
04/2021
1Hiatal Hernia
04/2021
1Nausea
04/2021
1Abdominal Pain (Pain, Abdominal)
04/2021
1Insulin Resistance
05/2020
1Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
06/2018
1Chronic Kidney Failure (Chronic Renal Failure)
11/2017
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
12/2013
1Anemia
12/2013
1Body Weight (Weight, Body)
11/2009
1Adenocarcinoma
09/2009
1Sepsis (Septicemia)
12/2007
1Urinary Incontinence
11/2007
1Urge Urinary Incontinence (Urge Incontinence)
11/2007
1Immune System Diseases (Immune Disorders)
03/2007
1Protein-Energy Malnutrition (Marasmus)
09/2006
1Pathologic Constriction (Stenosis)
04/2006
1Embolism (Embolus)
04/2006
1Respiratory Insufficiency (Respiratory Failure)
04/2006
1Gastroesophageal Reflux (GERD)
11/2005
1Hemorrhage
09/2005
1Venous Thromboembolism
08/2005
1Ovarian Diseases (Ovarian Disease)
10/2004
1Primary Hyperparathyroidism
12/2003
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
12/2003
1Ascites
02/2003

Drug/Important Bio-Agent (IBA)

7NF-kappa B (NF-kB)IBA
05/2008 - 05/2002
6Caspase 3 (Caspase-3)IBA
05/2008 - 02/2003
5CytokinesIBA
11/2009 - 05/2002
4Pancreatic Elastase (Elastase)IBA
06/2006 - 05/2002
3protein kinase C zetaIBA
05/2008 - 10/2007
3Proteins (Proteins, Gene)FDA Link
05/2008 - 12/2004
3Indicators and Reagents (Reagents)IBA
04/2005 - 02/2004
2AdiponectinIBA
11/2010 - 11/2009
2EthionineIBA
05/2008 - 06/2006
2Messenger RNA (mRNA)IBA
05/2008 - 12/2004
2Choline (Choline Chloride)IBA
05/2008 - 06/2006
2CeruletideIBA
10/2007 - 12/2004
2salicylhydroxamic acid (SHAM)IBA
12/2004 - 02/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2003 - 05/2002
1AntioxidantsIBA
05/2020
1Insulin (Novolin)FDA Link
05/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2020
1Vitamin EFDA LinkGeneric
05/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1IronIBA
12/2013
1MicronutrientsIBA
12/2013
1ferrous sulfateFDA Link
12/2013
1cytochrome C oxidase subunit IIIBA
05/2013
1Adiponectin ReceptorsIBA
11/2009
1Transcription Factors (Transcription Factor)IBA
11/2009
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2008
1Pharmaceutical PreparationsIBA
03/2007
1AntidiarrhealsIBA
09/2006
1Small Interfering RNA (siRNA)IBA
06/2006
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
04/2006
1DNA (Deoxyribonucleic Acid)IBA
01/2006
1NF-KappaB Inhibitor alphaIBA
01/2006
1LigandsIBA
01/2006
1AnticoagulantsIBA
08/2005
1fas Receptor (CD95 Antigen)IBA
12/2004
1GadoliniumIBA
12/2004
1Fas Ligand Protein (Fas Ligand)IBA
12/2004
1SB 203580IBA
02/2003
13,3'-dihexyl-2,2'-oxacarbocyanineIBA
02/2003

Therapy/Procedure

17Bariatric Surgery
04/2021 - 02/2002
17Gastric Bypass (Roux-en-Y Gastric Bypass)
04/2021 - 02/2003
1Gastrectomy
04/2021
1Orthopedic Procedures
01/2021
1Organ Transplantation
11/2017
1Transplantation
11/2017
1Contraindications
11/2017
1Kidney Transplantation
11/2017
1Renal Dialysis (Hemodialysis)
11/2017
1Esophagectomy
09/2009
1Punctures
12/2007
1Ligation
12/2007
1Length of Stay
10/2007
1Splenectomy
09/2005
1Vena Cava Filters (Inferior Vena Cava Filter)
08/2005
1Parathyroidectomy
12/2003